Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...
Hone Health reports that, when it comes to slowing aging and extending lifespan, few interventions are as well-supported by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback